ZIMMERMANN, B.; STARKE, G.; SHAW, D.; ELGER, B.; KONÉ, I. Actionability and scope should determine the extent of counselling for presymptomatic genetic testing. Swiss Medical Weekly, [S. l.], v. 150, n. 2728, p. w20274, 2020. DOI: 10.4414/smw.2020.20274. Disponível em: https://smw.ch/index.php/smw/article/view/2821. Acesso em: 12 jul. 2024.